Clinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trial

Phytomedicine

Volumn 23, Issue 11, 2016, Pages 1211-1219

  Maulik, Subir K ^a   Wilson, Vinu ^a,c   Seth, Sandeep ^a   Bhargava, Balram ^a   Dua, Pamila ^a   Ramakrishnan, Sivasubramanian ^a   Katiyar, Chandra K ^b,d  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Dabur India Limited   (India)

^c GOVERNMENT MEDICAL COLLEGE   (India)

^d Emami Limited   (India)

Author keywords

Arjuna; Ayurveda; Cardiac failure; Cardiovascular disease; Herbal drug; Terminalia arjuna

Indexed keywords

ALANINE AMINOTRANSFERASE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CARDIOVASCULAR AGENT; CATALASE; CHOLESTEROL; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLAVONOID; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; POLYPHENOL; SAPONIN; SUPEROXIDE DISMUTASE; TERMINALIA ARJUNA EXTRACT; TERPENOID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UREA; PLANT EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VASODILATOR AGENT;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AYURVEDA; BARK; BILIRUBIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GAIT; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PALPITATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PHARMACEUTICAL CARE; PLANT STEM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SIX MINUTE WALK TEST; SUDDEN CARDIAC DEATH; TERMINALIA ARJUNA; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS; UREA BLOOD LEVEL; AGED; CHEMISTRY; CHRONIC DISEASE; DRUG EFFECTS; HEART LEFT VENTRICLE FUNCTION; INDIA; METABOLISM; MIDDLE AGED; TERMINALIA; TREATMENT OUTCOME;

ADULT; AGED; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE; HUMANS; INDIA; MALE; MEDICINE, AYURVEDIC; MIDDLE AGED; PLANT BARK; PLANT EXTRACTS; PLANT STEMS; QUALITY OF LIFE; TERMINALIA; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 84960540540     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2016.02.007     Document Type: Article

References (41)

1. Bharani, A., Ganguly, A., Bhargava, K.D., Salutary effect of Terminalia arjuna in patients with severe refractory heart failure. Int. J. Cardiol. 49 (1995), 191–199.
2. Bharani, A., Ganguly, A., Mathur, L.K., Jamra, Y., Raman, P.G., Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. Indian Heart J. 54 (2002), 170–175.
3. Dandona, P., Ghanim, H., Brook, D., Antioxidant activity of carvedilol in cardiovascular disease. J. Hypertens. 25 (2007), 731–741.
4. Department of AYUSH, 2011. Terminalia arjuna. The Ayurvedic Pharmacopoeia of India. Ministry of Health and Family Welfare. Government of India, New Delhi, pp. 24-27.
5. Duckers, H.J., Houtgraaf, J., Hehrlein, C., Schofer, J., Waltenberger, J., Gershlick, A., Bartunek, J., Nienaber, C., Macaya, C., Peters, N., Smits, P., Siminiak, T., van Mieghem, W., Legrand, V., Serruys, P.W., Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial. EuroIntervention J 6 (2011), 805–812.
6. Dwivedi, S., Agarwal, M., Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. J. Assoc. Phys. India 42 (1994), 287–289.
7. Dwivedi, S., Chopra, D., Revisiting Terminalia arjuna - an ancient cardiovascular drug. J. Tradit. Complement. Med. 4 (2014), 224–231.
8. Dwivedi, S., Somani, P.N., Chansouria, J.P., Udupa, K.N., Cardioprotective effects of certain indigenous drugs in myocardial ischemia in rabbits. Indian J. Exp. Biol. 26 (1988), 969–975.
9. Ellman, G.L., Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82 (1959), 70–77.
10. Garin, O., Ferrer, M., Pont, A., Rué, M., Kotzeva, A., Wiklund, I., Van Ganse, E., Alonso, J., Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses. Qual. Life Res. 18 (2009), 71–85.
11. Gauthaman, K., Maulik, M., Kumari, R., Manchanda, S.C., Dinda, A.K., Maulik, S.K., Effect of chronic treatment with bark of Terminalia arjuna: a study on the isolated ischemic-reperfused rat heart. J. Ethnopharmacol. 75 (2001), 197–201.
12. Greenberg, B., Quinones, M.A., Koilpillai, C., Limacher, M., Shindler, D., Benedict, C., Shelton, B., Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation 91 (1995), 2573–2581.
13. Green, C.P., Porter, C.B., Bresnahan, D.R., Spertus, J.A., Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J. Am. Coll. Cardiol. 35 (2000), 1245–1255.
14. Guyatt, G.H., Sullivan, M.J., Thompson, P.J., Fallen, E.L., Pugsley, S.O., Taylor, D.W., Berman, L.B., The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can. Med. Assoc. J. 132 (1985), 919–923.
15. Hjalmarson, A., Goldstein, S., Fagerberg, B., Wedel, H., Waagstein, F., Kjekshus, J., Wikstrand, J., El Allaf, D., Vítovec, J., Aldershvile, J., Halinen, M., Dietz, R., Neuhaus, K.L., Jánosi, A. Thorgeirsson, G., Dunselman, P.H., Gullestad, L., Kuch, J., Herlitz, J., Rickenbacher, P., Ball, S., Gottlieb, S. Deedwania, P., Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 283 (2000), 1295–1302.
16. Hoekstra, T., Jaarsma, T., van Veldhuisen, D.J., Hillege, H.L., Sanderman, R., Lesman-Leegte, I., Quality of life and survival in patients with heart failure. Eur. J. Heart Fail. 15 (2013), 94–102.
17. Kakkar, P., Das, B., Viswanathan, P.N., A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys. 21 (1984), 130–132.
18. Kumar, S., Enjamoori, R., Jaiswal, A., Ray, R., Seth, S., Maulik, S.K., Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.). J. Pharm. Pharmacol 61 (2009), 1529–1536.
19. Lang, R.M., Bierig, M., Devereux, R.B., Flachskampf, F.A., Foster, E., Pellikka, P.A., Picard, M.H., Roman, M.J., Seward, J., Shanewise, J.S., Solomon, S.D., Spencer, K.T., Sutton, M.S.J., Stewart, W.J., Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. Off. Publ. Am. Soc. Echocardiogr. 18 (2005), 1440–1463.
20. Lee, J.K., Grace, K.A., Foster, T.G., Crawley, M.J., Erowele, G.I., Sun, H.J., Turner, P.T., Sullenberger, L.E., Taylor, A.J., How should we measure medication adherence in clinical trials and practice?. Ther. Clin. Risk Manage. 3 (2007), 685–690.
21. Lewis, E.F., Lamas, G.A., O'Meara, E., Granger, C.B., Dunlap, M.E., McKelvie, R.S., Probstfield, J.L., Young, J.B., Michelson, E.L., Halling, K., Carlsson, J., Olofsson, B., McMurray, J.J.V., Yusuf, S., Swedberg, K., Pfeffer, M.A., CHARM Investigators. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. Eur. J. Heart Fail. 9 (2007), 83–91.
22. Lubien, E., DeMaria, A., Krishnaswamy, P., Clopton, P., Koon, J., Kazanegra, R., Gardetto, N., Wanner, E., Maisel, A.S., Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105 (2002), 595–601.
23. Maulik, S.K., Katiyar, C.K., Terminalia arjuna in cardiovascular diseases: making the transition from traditional to modern medicine in India. Curr. Pharm. Biotechnol 11 (2010), 855–860.
24. Maulik, S.K., Talwar, K.K., Therapeutic potential of Terminalia Arjuna in cardiovascular disorders. Am. J. Cardiovasc. Drugs 12 (2012), 157–163.
25. McMurray, J.J.V., Adamopoulos, S., Anker, S.D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., Gomez-Sanchez, M.A., Jaarsma, T., Køber, L., Lip, G.Y.H., Maggioni, A.P., Parkhomenko, A., Pieske, B.M., Popescu, B.A., Rønnevik, P.K., Rutten, F.H., Schwitter, J., Seferovic, P., Stepinska, J., Trindade, P.T., Voors, A.A., Zannad, F., Zeiher, A., ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 33 (2012), 1787–1847.
26. Münzel, T., Gori, T., Keaney, J.F., Maack, C., Daiber, A., Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications. Eur. Heart J. 36 (2015), 2555–2564.
27. Oberoi, L., Akiyama, T., Lee, K.H., Liu, S.J., The aqueous extract, not organic extracts, of Terminalia arjuna bark exerts cardiotonic effect on adult ventricular myocytes. Phytomedicine 18 (2011), 259–265.
28. Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979), 351–358.
29. Parissis, J.T., Farmakis, D., Nieminen, M., Classical inotropes and new cardiac enhancers. Heart Fail. Rev. 12 (2007), 149–156.
30. Pawar, R.S., Bhutani, K.K., Effect of oleanane triterpenoids from Terminalia arjuna-a cardioprotective drug on the process of respiratory oxyburst. Phytomedicine 12 (2005), 391–393.
31. Radhakrishnan, R., Wadsworth, R.M., Gray, A.I., Terminalia arjuna, an ayurvedic cardiotonic, increases contractile force of rat isolated atria. Phytother. Res. 7 (1993), 266–268.
32. Rao, B.C.S., Singh, R.H., Tripathi, K., Effect of Terminalia arjuna (W&A) on regression of LVH in hypertensives: a clinical study. J. Res. Ayurveda Siddha 22 (2001), 216–227.
33. Rehsia, N.S., Dhalla, N.S., Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failure. Exp. Clin. Cardiol. 15 (2010), e86–e95.
34. Shahriar, M., Akhter, S., Hossain, M.I., Haque, M.A., Bhuiyan, M.A., Evaluation of in vitro antioxidant activity of bark extracts of Terminalia arjuna. J. Med. Plants Res. 6 (2012), 5286–5298.
35. Sinha, A.K., Colorimetric assay of catalase. Anal. Biochem. 47 (1972), 389–394.
36. Takahashi, S., Tanaka, H., Hano, Y., Ito, K., Nomura, T., Shigenobu, K., Hypotensive effect in rats of hydrophilic extract from Terminalia arjuna containing tannin-related compounds. Phytother. Res. 11 (1997), 424–427.
37. Tsutsui, H., Kinugawa, S., Matsushima, S., Oxidative stress and heart failure. Am. J. Physiol. Heart Circ. Physiol. 301 (2011), H2181–H2190.
38. Varghese, A., Savai, J., Pandita, N., Gaud, R., In vitro modulatory effects of Terminalia arjuna, arjunic acid, arjunetin and arjungenin on CYP3A4, CYP2D6 and CYP2C9 enzyme activity in human liver microsomes. Toxicol. Rep. 2 (2015), 806–816.
39. Verma, S.K., Bordia, A., Effect of Terminalia arjuna bark (arjun chhal) in patients of congestive heart failure and hypertension. J. Res. Educ. Indian Med. 7 (1988), 31–36.
40. Wiklund, I., Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life. Fundam. Clin. Pharmacol. 18 (2004), 351–363.
41. Zuluaga, M.C., Guallar-Castillón, P., López-García, E., Banegas, J.R., Conde-Herrera, M., Olcoz-Chiva, M., Rodríguez-Pascual, C., Rodriguez-Artalejo, F., Generic and disease-specific quality of life as a predictor of long-term mortality in heart failure. Eur. J. Heart Fail. 12 (2010), 1372–1378.